Examining the impact of synovectomy on pain relief after knee replacement surgery
Official title: The Role of Synovectomy in Pain Reduction Among Osteoarthritis Patients Following Total Knee Arthroplasty
Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT05800457 · Data updated 2026-11-12
This study is testing if removing inflamed tissue during knee replacement surgery can help people with osteoarthritis feel less pain and be happier with their results.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 41 Years to 80 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Academic / other |
| Drugs / interventions | methotrexate |
| Locations | 1 site (London, Ontario) |
| Status | Recruiting |
| Started | November 20, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT05800457 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals over 40 years old with knee osteoarthritis and moderate to severe synovitis scheduled for their first unilateral TKA.
✕Probably not a fit
Patients with bilateral or revision knee surgeries, inflammatory arthropathies, or those who cannot understand English may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of performing a synovectomy during total knee arthroplasty (TKA) for patients suffering from osteoarthritis and moderate to severe synovitis. The procedure involves removing the inflamed synovial tissue to potentially reduce post-surgical pain and improve patient satisfaction. By including 62 patients scheduled for their first unilateral TKA, the study aims to assess the short-term benefits of this intervention. The outcomes will help determine if synovectomy can lead to better pain management and overall satisfaction in patients who are likely to experience dissatisfaction after TKA.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and satisfaction for patients undergoing knee replacement surgery.
How similar studies have gone: While the specific approach of synovectomy during TKA is less commonly studied, similar interventions targeting synovitis have shown promise in improving outcomes in other contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Males or females over the age of 40 diagnosed with knee osteoarthritis 2. Scheduled for first unilateral total knee arthroplasty 3. Moderate to severe (at least grade two) synovitis and synovial hyperplasia, as determined by ultrasound assessment 4. Referred to the Pre-Admission Clinic at University Hospital Exclusion Criteria: 1. Bilateral, uni-compartmental, or revision total knee arthroplasty 2. Osteoarthritis due to genetic syndromes (e.g., Ehlers-Danlos Syndrome, etc.) 3. Known inflammatory arthropathy, another rheumatic disease, or disease-modifying anti-rheumatic drug (DMARD) use (e.g. methotrexate, hydroxychloroquine, sulfasalazine, leflunomide, TNF inhibitors, etc.) - note: Gout is NOT an exclusion 4. Joint injection (steroid or viscosupplement) within 12 weeks of Pre-Admission Clinic appointment date 5. Cannot read, write, or understand English (printed instructions are provided in English only) 6. Any factors precluding patients from attending follow-up appointments (e.g., socio-economic limitations, distance from clinic, no access to home/cell phone, etc.). 7. Cognitive impairment or psychological problems that preclude the ability to understand instructions 8. Not able to follow up at routine standard of care post-operative visits
Where it's running
-
London Health Sciences Centre - University Hospital
London, Ontario, Canada Recruiting
Study contacts
- Study coordinator: Lyndsay E Somerville, PhD
- Email: lyndsay.somerville@lhsc.on.ca
- Phone: 5196858500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Undenatured Type II Collagen for Knee Osteoarthritis Pain (Three-Arm Trial)
This study tests whether taking undenatured type II collagen capsules once daily for 4 months can reduce knee pain in adults with knee osteoarthritis, compared with two collagen formulations and a placebo.
-
Serum Fetuin‑A and COMP levels in knee osteoarthritis
This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.
-
Pain relief for knee osteoarthritis: a 2nd phase study of LY4065967 vs placebo
Researchers are testing whether LY4065967 can help reduce knee pain from osteoarthritis in adults, compared with placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.